Giuseppe Bertuglia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Giuseppe Bertuglia has a total of 171 co-authors. Here are the top co-authors by number of shared publications:
- Francesca Gay
Divisione di Ematologia 1, AOU Città Della Salute e Della Scienza di Torino, 10126 Torino, Italy
24 shared publications - Mattia D'AGostino
Division of Hematology, Department of Molecular Biotechnology and Health Sciences, AOU Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy
23 shared publications - Aitziber Lopez
Universidad de Navarra (CIMA) 1 Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada IDISNA, CIBER-ONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain
22 shared publications - Alejandro Medina-Herrera
Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain
22 shared publications - Alice Nevone
University of Pavia 6 Department of Molecular Medicine Pavia, Italy
22 shared publications - Bruno Paiva
Cancer Center Clínica Universidad de Navarra (CCUN), Centro de Investigación Médica Aplicada (CIMA LAB Diagnostics), IDISNA, CIBERONC, Pamplona, Spain
22 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Table S8 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
List of somatic mutations detected in normal cells.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S8 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
List of somatic mutations detected in normal cells.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Distribution of B-cell differentiation stages.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Distribution of B-cell differentiation stages.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Figure S12 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Overall survival (OS) according to MRD.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S12 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Overall survival (OS) according to MRD.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Frequency of non-clonotypic clones.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Frequency of non-clonotypic clones.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Table S1 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Characteristics and methods of study cohorts.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Characteristics and methods of study cohorts.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Table S7 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Number of somatic variants detected in normal cells.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S7 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Number of somatic variants detected in normal cells.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Differentially expressed genes in non-clonotypic cells.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Differentially expressed genes in non-clonotypic cells.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Figure S9 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Differentially expressed genes in clonotypic cells.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Differentially expressed genes in clonotypic cells.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Table S5 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Differentially expressed genes in clonotypic cells.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Differentially expressed genes in clonotypic cells.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Oligoclonal expansions in non-clotypic cells.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers
Oligoclonal expansions in non-clotypic cells.